| Literature DB >> 33485605 |
Kanika Khanna1, Sukhmeen Kaur Kohli1, Ravdeep Kaur1, Abhay Bhardwaj2, Vinay Bhardwaj2, Puja Ohri3, Anket Sharma4, Ajaz Ahmad5, Renu Bhardwaj6, Parvaiz Ahmad7.
Abstract
Current scenario depicts that world has been clenched by COVID-19 pandemic. Inevitably, public health and safety measures could be undertaken in order to dwindle the infection threat and mortality. Moreover, to overcome the global menace and drawing out world from moribund stage, there is an exigency for social distancing and quarantines. Since December, 2019, coronavirus, SARS-CoV-2 (COVID-19) have came into existence and up till now world is still in the state of shock.At this point of time, COVID-19 has entered perilous phase, creating havoc among individuals, and this has been directly implied due to enhanced globalisation and ability of the virus to acclimatize at all conditions. The unabated transmission is due to lack of drugs, vaccines and therapeutics against this viral outbreak. But research is still underway to formulate the vaccines or drugs by this means, as scientific communities are continuously working to unravel the pharmacologically active compounds that might offer a new insight for curbing infections and pandemics. Therefore, the topical COVID-19 situation highlights an immediate need for effective therapeutics against SARS-CoV-2. Towards this effort, the present review discusses the vital concepts related to COVID-19, in terms of its origin, transmission, clinical aspects and diagnosis. However, here, we have formulated the novel concept hitherto, ancient means of traditional medicines or herbal plants to beat this pandemic.Entities:
Keywords: Herbal plants; Immune-System Rebooting; Natural therapeutics; PAK-1 Blockers; SARS-CoV-2; Traditional medicine
Year: 2020 PMID: 33485605 PMCID: PMC7532351 DOI: 10.1016/j.phymed.2020.153361
Source DB: PubMed Journal: Phytomedicine ISSN: 0944-7113 Impact factor: 5.340
Fig. 1Schematic Presentation of COVID-19 Binding to Host Cells, Invasion, Replication, Assemblage, Release and Infection Along with the Associated Host and Viral Factors. Fig. illustrates the origin of coronavirus from bats; the viral structure comprises of spike proteins that enable attachment and virus is enveloped in nature for protection as well as facilitation of viral entry; the viral particles bind onto ACE2 receptors of host cells; clathrin is associated with coating membranes for endocytosis from the plasma membrane; viral particles are invaded and fused followed by replication; assembly and release of viral particles occurs to initiate the infection process.
Fig. 2Prospects of Augmentation in Immuno-Modulatory Responses against COVID-19 by Polyphenols/Flavonoids and Terpenoids.
Herbal Formulations as Possible Therapeutics against COVID-19 Infection.
| 1. | Cannabinoid cannabidiol | Anti-inflammatory action by via modulation of gene expression of ACE2 enzyme, serine protease TMPRSS2, protein pre-requisite for SARS-CoV2 invasion into host cells. | Adjunct therapy and utilised as mouthwash and throat gargle products clinically and home use owing to their potential to decrease viral entry via the oral mucosa. | ( | |
| 2. | Glycyrrhizin, glycyrrhetic acid, liquiritin and isoliquiritin | Counterbalance the activeness of COVID-19 and could be used as an antiviral drug. | Formation of antiviral nano-membrane by licorice processed with PVA solution for potential application as wound dressing materials, musk, gloves and against skin infection by electrospinning. | ( | |
| 3. | Essential oils, pectins, naringin and hesperidin (flavonoids). | Binds with high affinity to cellular receptors of SARS-CoV-2 that restrain the pro-inflammatory overreaction of the immune system. | Prophylaxis and treatment of COVID-19. | ( | |
| 4. | Sulfated polysaccharides (carrageenan) | Potent inhibitors of coronaviruses that inhibit the binding or internalization of virus into the host cells. | Biocompatible compounds can be used as a coating material on the sanitary items for COVID-19 prevention. | ( | |
| 5. | Hispidin, lepidine E,and folic acid | Inhibition of 3CL hydrolase enzyme known for counteracting the host innate immune response and explain the main interactions in inhibitor-enzyme complex. | Promising therapeutic principle for developing drug candidates as anti-CoViD-19 drug. | ( | |
| 6. | Benzene 123 Triol | Immuno-modulatory activity against ACE2 enzyme receptor, that routes virus entry in the pathogenesis of Novel coronavirus. | Potent anti-viral capacity for drug development. | ( | |
| 7. | Curcumin, Anolignan A, Phyllamyricin B | May act as molecular blockers for the virus or cell surface receptors. | Can be useful alternative potential drug. | ( | |
| 8. | Nigelledine, α- Hederin | Inhibitory action of proteases; CoVs (3CLpro/Mpro) (PDB ID | Best potential to act in COVID-19 treatment, testified medicinal use for preventive purpose. | ( | |
| 9. | Polyphenols (Sanguiin, Theaflavin gallate, Theaflavin digallate, Kaempferol, Punicalagin and Protocatechuic acid) | Target COVID-19 main protease (Mpro), key enzyme of coronavirus involved in virus replication and transcription, and impedes viral growth inside the host. | Dietary intake of black tea aids resistance to fight against COVID-19 virus in early stages of human infection. | ( | |
| 10. | 6-gingerol | Higher binding affinity at active sites of R7Y COVID-19, main protease essential for replication and reproduction of SARS Cov-2 | Possesses excellent drug likeliness parameters with zero violations. | ( | |
| 11. | Naringin, Naringenin, Hesperetin and Hesperidin | Inhibited expression of pro-inflammatory cytokines (COX-2, iNOS, IL-1β and IL-6) in macrophage cell line, restrained cytokines via inhibiting HMGB1 expression in a mouse model and impeded binding affinity of ACE 2, receptor of the coronavirus. | Contemplation of potential anti-coronavirus and anti-inflammatory activity of flavonoids, derived phytochemicals are promising in the use of prevention and treatment of 2019-nCoV infection. | ( | |
| 12. | Fraxetin 1(3H)-isobenzofuranone | Phytochemical, cytotoxicity and anti-inflammatory actions confirmed in fractions of extract as observed as a potent constituents. | Cytotoxic compounds, warrant research to fabricate suitable formulations comprising these constituents. | ( | |
| 13. | Diallyl Disulfide, Curcumin, Capsaicin, Limonene, Thymol, Verbascoside, Glucouronic acid | Restrained viral protease enzyme by inhibiting amino acid synthesis. | Compounds investigated especially, Curcumin could be strongest achiever against COVID-19. | ( | |
| 14. | Oleanolic acid, Ursolic acid, Curcumin, Rosmarinic acid, Eugenol, Magnoflorine, Berberine, Piperine, Piperamide, Piperamine 6-gingerol, Quercetin, Hesperetin, Protocatechualdehyde, Caryophyllene,Withaferin | Higher binding affinity with viral and host macromolecular targets and other human pro-inflammatory mediators, SARS-CoV-2 main proteases, spike, human ACE2 and furin proteins. | Regularly consumped in the form of ayurvedic Kadha to boost immunity and dwindle chances of COVID-19 Infection. | ( | |
| 15. | Phenols, Flavonoids, Flavonones and Hydroflavonoles | Highest ACE2 enzyme inhibition, anti-inflammatory activity, modulated α-gene expression for TNF- production in macrophages. | Bioactive compounds could be used for drug formulations. | ( | |
| 16. | Baicalein | Anti-SARS-CoV-2 activity via suppressing SARS-CoV-2 3CLpro and replication. | Effective compounds as anti-SARS-CoV-2 inhibitors. | ( | |
| 17. | Ginkgolic acids | Impeded DNA and protein synthesis by binding towards host cell receptors to activate cell-signaling pathways for arresting cell cycle as an inhibitory action. | Sturdy effect of GA on viral infection, to be potentially used to treat coronavirus infections. | ( | |
| 18. | Essential oil, Allyl disulfide, Allyl trisulfide | Acted as ACE2 receptor inhibitor for resistance against Coronavirus along with activity against main proteases of SARS-CoV-2. | Essential oil as valuable natural antivirus source, contributing towards preventing the invasion of coronavirus into the human body. | ( | |
| 19. | Curcumin, Hesperidin, Galangin and Brazilin | Anti-SARS-CoV-2 through its binding to 3-protein receptors with good affinity performing an inhibitory potential against viral infection and replication. | Consumed in daily life as prophylaxis of COVID-19. | ( | |
| 20. | Curcumin and Gingerol | SARS-CoV-2 papain-like protease (PLpro) inhibitors. | Potent drugs to treat corona infections. | ( | |
| 21. | Myricitrin, Methyl Rosmarinate, 5,7,3′,4′-Tetrahydroxy-2′-(3,3- dimethylallyl) isoflavone, 3,5,7,3′,4′,5′-hexahydroxy flavanone-3-Obeta-D-glucopyranoside, Myricetin 3 Obeta-D-glucopyranoside, Amaranthin, Licoleafol | Inhibited SARS-CoV-2 3CL pro-activity and virus replication. | Probable inhibitors into clinical drugs for exploring and developing novel natural anti-COVID-19 therapeutic agents in the future. | ( | |
| 22. | Nictoflorin Astragalin, Lupeol Berberine,Sitosterol, Aloenin, Aloesin, Curcumin, Nimbin, Withanolide, Withaferin A, Shogaol, Quercetin, Ursolic acid, Apigenin, Cannabidiol,Piperine, Gingerol | Potential inhibitors of COVID-19 proteases. | Promising development of herbal medicines. | ( | |
| 23. | Curcumin, Nelfinavir, Lopinavir, Luteolin-7-glucoside, Demethoxycurcumin, Apigenin-7-glucoside, Oleuropein, Catechin, and epicatechin-gallate | Best potential to act as COVID-19 Mpro inhibitors. | Treatment and prophylaxis | ( | |
| 24. | Ginkgolide A, Terpenoids | Stronger bond and high affinity with proteases. | Compounds may be considered as effective COVID_19 antiproteases drugs. | ( | |
| 25. | Epigallocatechin gallate | Targets include main proteases covid-19, post fusion core of 2019-nCoV S2 subunit, prefusion spike glycoproteins and NSP15 endoribonuclease from SARS CoV-2. | Future drug candidate for COVID-19. | ( | |
| 26. | Silybin, Withaferin A | SARSCoV-2 inhibitors namely, Spike (S) glycoproteins, main protease (Mpro) and RNA-dependent RNA-polymerases (RdRp) | Could be useful traditional medicine for treatment for COVID-19 infection. | (Pandit, 2020) | |
| 27. | Hesperidin, Rutin, Diosmin, Apiin, Diacetyl curcumin | Inhibitory action against SARS-CoV-2 main protease (Mpro). | Medicinal potential to cure COVID-19. | ( | |
| 28. | Flavonoids and Naringin | Antitussive, expectorant, improved lung function, pulmonary fibrosis, and antiviral immune response. | Reference for its clinical application in the prevention and treatment of multiple respiratory diseases, including coronavirus disease. | ( | |
| 29. | Jensenone | COVID-19 Mpro inhibitor | Eucalyptus oil could be use for prevention and cure. | ( | |
| 30. | Herbacetin, Isobavachalcone, Quercetin, 3‐β‐d‐glucoside, Helichrysetin and Betulinic acid | Inhibitory compounds against MERS‐CoV 3C‐like proteases (3CLpro). | Flavonoids with these characteristics can be used as templates to develop potent MERS‐CoV 3CLpro inhibitors. | ( | |
| 31. | 6-Shogaol, 6-Gingerol, Beta Sitosterol, Piperidine, Apigenin, Piperine, Quercetin, Chlorogenic Acid, Andrographolide, Bharangin, Carvacrol, Cissamine,Costunolide, Cucurbitacin B, Gallic acid, Linoleic acid, Pellitorine, Rutin, Santalic acid, Cynaropicrin, Eugenol, Thymol and Vitexin) | Binding potential with active residues of ACE2 that mediate host viral interface. | Future systematic investigation could validate the efficacy prior to the recommendation. | ( |
Fig. 3Role of Vitamins (A, C, E and D) in combating COVID-19.
Fig. 4Signalling Pathway Underlying PAK1-Blockers and Viral Infections.